Business Development Director - CDMO

If you are unable to complete this application due to a disability, contact this employer to ask for an accommodation or an alternative application process.

Full‑Time Remote (US)

Salary Range: $ – $ annually

Variable Comp Plan: $

Location: Remote. Candidate to be located in the US and near a major airport.

The Business Development Director will be responsible for driving B2B growth in xenograft biomaterials, focusing on fresh tissue, fixed tissue, and collagen-based solutions across key clinical segments including Spine, Sports & Orthopedics, Cardiac, and Plastic & Reconstructive surgery. This role requires deep expertise in xenograft processing, applications, and value propositions within a CDMO environment.

• Prospect strategic targets with a focus on companies developing products utilizing xenograft biomaterials (fresh tissue, fixed tissue, and collagen), identifying opportunities aligned with our processing and manufacturing capabilities.
• Develop Key Account Strategies aligned to clients’ xenograft sourcing, processing, and commercialization needs, positioning Evergen as a strategic CDMO partner.
• Build and maintain strong relationships with existing and potential clients, ensuring a deep understanding of their requirements and internal processes.
• Orchestrate cross‑functional collaboration (R&D, regulatory, and manufacturing) to develop and deliver customized xenograft-based solutions.
• Translate xenograft platform capabilities (e.g., decellularization, fixation, collagen processing) into customer‑specific value propositions.
• Identify and shape opportunities where xenograft materials can replace or outperform alternative biomaterials, driving differentiation for customers.
• Lead negotiations and close deals, ensuring favorable terms for the company and high levels of client satisfaction.
• Monitor market trends and competitor activities to identify opportunities for growth and differentiation.
• Prepare for and represent the company at industry conferences, trade shows, and other networking events to promote our capabilities and expand our client base.
• Prepare and present regular reports on business development activities, pipeline status, and sales performance to senior management.
• Leverage CRM tools to maintain documentation of account planning, prospects, and pipeline development.

• Bachelor's degree in Business Administration, Marketing, or a related field; advanced degree preferred.
• Minimum of 4 years of experience in business development, sales, or a related role within the medical device industry, including at least 2 years within a medical device CDMO environment.
• Deep understanding of xenograft biomaterials, including fresh tissue, fixed tissue, and collagen (fibrillar, solubilized, or formulated), and their applications in medical devices.
• Experience working with xenograft sourcing, processing, or manufacturing (e.g., decellularization, sterilization, or collagen processing).
• Proven track record of achieving sales targets and driving revenue growth.
• Excellent communication, negotiation, and interpersonal skills.
• Ability to work collaboratively with cross‑functional teams and manage multiple projects simultaneously.
• Strategic thinker with strong analytical and problem‑solving skills.
• Willingness to travel as needed to meet with clients and attend industry events.

• Experience with xenograft-based product development or commercialization within a CDMO or OEM environment.
• Familiarity with regulatory and quality considerations specific to xenograft biomaterials.
• Established network of contacts within the medical device industry.
• Clinical expertise in focus market segments:
  Spine, Sports and Orthopedics, Cardiac, or Plastic and Reconstructive Surgery.

• Opportunity to shape and scale a leading xenograft CDMO platform across fresh tissue, fixed tissue, and collagen biomaterials.
• Collaborative and innovative work environment.
• Competitive salary and benefits package.
• Chance to make a significant impact on patient outcomes through advanced biomaterial solutions.

• Accountable:
  We own our actions.
• Growth Mindset:
  We learn continuously.

Montagu Private Equity acquired RTI Surgical in 2020 and continues to support Evergen’s transformation and long‑term growth strategy.